NCT05440383 2025-03-14
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Kissei Pharmaceutical Co., Ltd.
Phase 3 Completed
Clinical Trials
8 trialsNCT04192812 2020-06-23
PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERÄ°N FIBROIDS
Alkü Alanya Education and Research Hospital
Phase NA Unknown
NCT02361879 2016-11-18
Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
University Magna Graecia
Phase 4 Unknown
NCT02361905 2016-11-18
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
University Magna Graecia
Phase 4 Unknown
NCT02288130 2016-11-03
MYOMEX
Amsterdam UMC, location VUmc
Phase 4 Unknown
NCT00683917 2014-08-21
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Terminated
NCT01069094 2014-06-30
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Repros Therapeutics Inc.
Phase 1/2 Completed
NCT00776074 2010-06-22
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
Takeda
Phase 2 Completed